A brief note for brief therapists
In the last 24 hours, the posting at:
Petition: Limit promotion and delivery of CBT within the NHS
posted over six months ago, on 18 May, has attracted an extraordinary number of hits.
The comment facility for this posting is being targeted by practitioners of Solution Focused Brief Therapy who are all members of the United Kingdom Association for Solution Focused Practice http://www.ukasfp.co.uk/index.cfm
I have let the first of these comments through, though it has been necessary for me to contact the author of the comment to advise that the URL to his personal web page would need to be omitted as it is in breach of WordPress Terms & Conditions to post links to commercial sites; Mr Hanton is a practitioner of SFT offering consultancy services to PCTs and other organisations, and private therapy to individual clients.
Although Mr Hanton did not declare his interest, he is also an Office Bearer for the General Committee of the Company the United Kingdom Association for Solution Focused Practice, being one of its Co-Chairs http://www.ukasfp.co.uk/ukasfp/committee.cfm
One of the other individuals who also submitted comments (but who similarly did not declare their interest) is also listed as a Committee Member for the Company the United Kingdom Association for Solution Focused Practice.
I am treating a significant number of additional comments, received last night and this morning from other individuals who are listed on the UKASFP Company website as being members of the United Kingdom Association for Solution Focused Practice, as spam and the comment facility for this posting has now been turned off.
Would practitioners of the Lightning Process, Mickel Therapy and Reverse Therapy also note that it would be in breach of WordPress Terms & Conditions to post links driving traffic to the sites of practitioners offering training, consultancies or private therapy.
It’s not clear whether the sudden focus of interest in this particular posting relates to the issue of the petition concerning the promotion and delivery of CBT within the NHS, the issue of the effectiveness or not of CBT in general or in relation to specific conditions, or whether the author of the comment and fellow members of the UK Association for Solution Focused Practice have a specific interest in promoting the use of Solution Focused Practice in conditions such as chronic fatigue or chronic fatigue syndrome.
However, if members of the UK Association for Solution Focused Practice have found their way to this site out of a genuine interest in educating themselves about the profoundly disabling neurological illness Myalgic encephalomyelitis, indexed by the WHO in ICD-10 at G93.3, then I suggest that they might usefully familiarise themselves with the following documents:
What is ME? What is CFS? INFORMATION FOR CLINICIANS AND LAWYERS, 2001
E.P. Marshall, M. Williams, Prof M. Hooper
The Canadian Consensus Document for ME/CFS
The Nightingale Definition of Myalgic encephalomyelitis
Byron Marshall Hyde MD, The Nightingale Research Foundation
Assessment and Treatment of Patients with ME/CFS: Clinical Guidelines for Psychiatrists
Dr Eleanor Stein MD FRCP
They might also usefully familiarise themselves with a series of documents produced for the forthcoming Judicial Review of the NICE Guidelines for “CFS/ME” (CG53) (Hearing listed for 11th-12th February 2009 in The High Court, Royal Courts of Justice, The Strand, London WC2A 2LL)
Background information and illustrations of evidence that CBT cannot improve ME/CFS which NICE disregarded, Margaret Williams 25 July 2008
Evidence that the Guideline Development Group that produced the NICE Guideline on CFS/ME (C53) failed to fulfil its remit (particularly in relation to the potential dangers of graded exercise therapy), Margaret Williams 7 July 2008
Evidence of cardiovascular problems in ME/CFS that NICE disregarded, Margaret Williams 4 August 2008
Immunological, neuroendocrine and neurological evidence (including evidence of CNS inflammation) documented in ME/CFS that NICE chose to ignore in the production of its Clinical Guideline 53, Margaret Williams 31 August 2008